News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
303,959 Results
Type
Article (16405)
Company Profile (302)
Press Release (287246)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (84447)
Career Advice (177)
Deals (14258)
Drug Delivery (41)
Drug Development (54097)
Employer Resources (32)
FDA (7239)
Job Trends (5741)
News (155801)
Policy (11692)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1034)
Accelerated approval (19)
Adcomms (16)
Allergies (97)
Alliances (22981)
ALS (139)
Alzheimer's disease (1044)
Antibody-drug conjugate (ADC) (257)
Approvals (7460)
Artificial intelligence (263)
Autoimmune disease (112)
Automation (9)
Bankruptcy (122)
Best Places to Work (5088)
BIOSECURE Act (6)
Biosimilars (118)
Biotechnology (231)
Bladder cancer (109)
Brain cancer (46)
Breast cancer (381)
Cancer (3254)
Cardiovascular disease (244)
Career advice (160)
Career pathing (7)
CAR-T (219)
CDC (18)
Cell therapy (569)
Cervical cancer (14)
Clinical research (46623)
Collaboration (1181)
Company closure (2)
Compensation (602)
Complete response letters (42)
COVID-19 (1485)
CRISPR (86)
C-suite (562)
Cystic fibrosis (129)
Data (4565)
Denatured (15)
Depression (95)
Diabetes (255)
Diagnostics (1773)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (192)
Drug pricing (53)
Drug shortages (4)
Duchenne muscular dystrophy (220)
Earnings (34021)
Editorial (26)
Employer branding (4)
Employer resources (30)
Events (54272)
Executive appointments (642)
FDA (9153)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (1008)
Gene editing (183)
Generative AI (21)
Gene therapy (496)
GLP-1 (516)
Government (1479)
Grass and pollen (6)
Guidances (188)
Healthcare (7198)
HIV (18)
Huntington's disease (43)
IgA nephropathy (75)
Immunology and inflammation (201)
Immuno-oncology (40)
Indications (71)
Infectious disease (1689)
Inflammatory bowel disease (161)
Inflation Reduction Act (10)
Influenza (83)
Intellectual property (169)
Interviews (23)
IPO (7776)
IRA (13)
Job creations (944)
Job search strategy (140)
JPM (42)
Kidney cancer (9)
Labor market (22)
Layoffs (266)
Leadership (9)
Legal (1596)
Liver cancer (43)
Longevity (11)
Lung cancer (436)
Lymphoma (259)
Machine learning (24)
Management (7)
Manufacturing (392)
MASH (130)
Medical device (3376)
Medtech (3385)
Mergers & acquisitions (7120)
Metabolic disorders (735)
Multiple sclerosis (108)
NASH (13)
Neurodegenerative disease (235)
Neuropsychiatric disorders (72)
Neuroscience (1993)
Neurotech (1)
NextGen: Class of 2026 (2184)
Non-profit (943)
Now hiring (31)
Obesity (338)
Opinion (127)
Ovarian cancer (132)
Pain (105)
Pancreatic cancer (162)
Parkinson's disease (235)
Partnered (12)
Patents (308)
Patient recruitment (336)
Peanut (48)
People (27636)
Pharmaceutical (46)
Pharmacy benefit managers (8)
Phase 1 (15938)
Phase 2 (21278)
Phase 3 (14342)
Pipeline (3442)
Policy (102)
Postmarket research (1106)
Preclinical (6732)
Press Release (31)
Prostate cancer (154)
Psychedelics (50)
Radiopharmaceuticals (239)
Rare diseases (678)
Real estate (1540)
Recruiting (13)
Regulatory (11239)
Reports (19)
Research institute (1043)
Resumes & cover letters (18)
Rett syndrome (26)
RNA editing (21)
RSV (80)
Schizophrenia (123)
Series A (185)
Series B (141)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (136)
Sponsored (16)
Startups (2064)
State (1)
Stomach cancer (6)
Supply chain (33)
Tariffs (19)
The Weekly (62)
Vaccines (510)
Venture capital (69)
Weight loss (178)
Women's health (25)
Worklife (2)
Date
Last 7 days (369)
Last 30 days (1268)
Last 365 days (18753)
2026 (1737)
2025 (19043)
2024 (21633)
2023 (23703)
2022 (28812)
2021 (30085)
2020 (26328)
2019 (17480)
2018 (12768)
2017 (14893)
2016 (12883)
2015 (15410)
2014 (11173)
2013 (8112)
2012 (8206)
2011 (8324)
2010 (8042)
Location
Africa (169)
Alabama (66)
Alaska (2)
Arizona (75)
Arkansas (5)
Asia (19504)
Australia (3369)
California (7255)
Canada (1906)
China (783)
Colorado (255)
Connecticut (292)
Delaware (295)
Europe (42711)
Florida (964)
Georgia (239)
Hawaii (3)
Idaho (20)
Illinois (425)
India (40)
Indiana (187)
Iowa (9)
Japan (254)
Kansas (83)
Kentucky (11)
Louisiana (11)
Maine (12)
Maryland (781)
Massachusetts (5750)
Michigan (111)
Minnesota (254)
Mississippi (3)
Missouri (33)
Montana (16)
Nebraska (5)
Nevada (41)
New Hampshire (34)
New Jersey (1816)
New Mexico (13)
New York (1797)
North Carolina (883)
North Dakota (7)
Northern California (3529)
Ohio (194)
Oklahoma (11)
Oregon (24)
Pennsylvania (1417)
Puerto Rico (9)
Rhode Island (25)
South America (238)
South Carolina (10)
Southern California (2893)
Tennessee (42)
Texas (934)
United States (24494)
Utah (126)
Virginia (149)
Washington D.C. (37)
Washington State (598)
West Virginia (1)
Wisconsin (49)
303,959 Results for "respira therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Respira Therapeutics Enters into Agreement with Gossamer Bio (Gossamer) Granting Gossamer Option to Acquire Respira from Samsara BioCapital
September 26, 2025
·
4 min read
Press Releases
Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension
September 26, 2025
·
7 min read
Press Releases
Respira Therapeutics Announces Late-breaking Presentation of RT234 Phase 2b PAH Clinical Trial Results at the American Thoracic Society (ATS) 2025 International Conference
May 19, 2025
·
1 min read
Press Releases
Kinaset Therapeutics Announces $103 Million Oversubscribed Series B Financing to Advance Novel, Inhaled Therapeutic Candidate for Respiratory Diseases
January 12, 2026
·
4 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Drug Development
Respira Therapeutics Announces First Patient Dosed in Phase 2b VIPAH-PRN 2b Trial of RT234 in Patients with Pulmonary Arterial Hypertension (PAH)
Respira Therapeutics, Inc. announced today that the first patient in the United States has been dosed in the multicenter trial of its lead product candidate, RT234-PAH (vardenafil administered as a dry powder inhaled treatment).
April 5, 2022
·
4 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
Press Releases
MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
December 23, 2025
·
6 min read
Press Releases
Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
December 15, 2025
·
4 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
1 of 30,396
Next
